Dynamin-like 120 kDa protein (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dynamin-like 120 kDa protein" in English language version.

refsWebsite

Global rank English rank

21nih.gov

4^th place

10doi.org

2^nd place

2ensembl.org

1,626^th place

1,007^th place

2semanticscholar.org

11^th place

8^th place

1mtak.hu

low place

9,835^th place

1worldcat.org

5^th place

doi.org

Votruba M, Moore AT, Bhattacharya SS (Jan 1998). "Demonstration of a founder effect and fine mapping of dominant optic atrophy locus on 3q28-qter by linkage disequilibrium method: a study of 38 British Isles pedigrees". Human Genetics. 102 (1): 79–86. doi:10.1007/s004390050657. PMID 9490303. S2CID 26060748.
Santarelli R, Rossi R, Scimemi P, Cama E, Valentino ML, La Morgia C, et al. (Mar 2015). "OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation". Brain: A Journal of Neurology. 138 (Pt 3): 563–576. doi:10.1093/brain/awu378. PMC 4339771. PMID 25564500.
Patten DA, Wong J, Khacho M, Soubannier V, Mailloux RJ, Pilon-Larose K, et al. (Nov 2014). "OPA1-dependent cristae modulation is essential for cellular adaptation to metabolic demand". The EMBO Journal. 33 (22): 2676–2691. doi:10.15252/embj.201488349. PMC 4282575. PMID 25298396.
Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, et al. (Mar 2014). "The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission". The Journal of Cell Biology. 204 (6): 919–929. doi:10.1083/jcb.201308006. PMC 3998800. PMID 24616225.
Wiemerslage L, Lee D (Mar 2016). "Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters". Journal of Neuroscience Methods. 262: 56–65. doi:10.1016/j.jneumeth.2016.01.008. PMC 4775301. PMID 26777473.
Carelli V, Musumeci O, Caporali L, Zanna C, La Morgia C, Del Dotto V, et al. (Mar 2015). "Syndromic parkinsonism and dementia associated with OPA1 missense mutations". Annals of Neurology. 78 (1): 21–38. doi:10.1002/ana.24410. PMC 5008165. PMID 25820230.
Fülöp L, Rajki A, Katona D, Szanda G, Spät A (Dec 2013). "Extramitochondrial OPA1 and adrenocortical function" (PDF). Molecular and Cellular Endocrinology. 381 (1–2): 70–79. doi:10.1016/j.mce.2013.07.021. PMID 23906536. S2CID 5657510.
McKenty T, Ali S, Sonntag D, Ravipaty S, Cui Y, Slate D, et al. (2024-10-01). "Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells". Nucleic Acid Therapeutics. 34 (5): 221–233. doi:10.1089/nat.2024.0022. ISSN 2159-3337. PMC 11564677. PMID 39264859.
Fülöp L, Szanda G, Enyedi B, Várnai P, Spät A (2011). "The effect of OPA1 on mitochondrial Ca²⁺ signaling". PLOS ONE. 6 (9): e25199. doi:10.1371/journal.pone.0025199. PMC 3182975. PMID 21980395.
Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, et al. (Jun 2015). "The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage". Cell Metabolism. 21 (6): 834–844. doi:10.1016/j.cmet.2015.05.007. PMC 4457892. PMID 26039448.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000198836 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000038084 – Ensembl, May 2017

mtak.hu

real.mtak.hu

Fülöp L, Rajki A, Katona D, Szanda G, Spät A (Dec 2013). "Extramitochondrial OPA1 and adrenocortical function" (PDF). Molecular and Cellular Endocrinology. 381 (1–2): 70–79. doi:10.1016/j.mce.2013.07.021. PMID 23906536. S2CID 5657510.

nih.gov

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: OPA1 optic atrophy 1 (autosomal dominant)".
Santarelli R, Rossi R, Scimemi P, Cama E, Valentino ML, La Morgia C, et al. (Mar 2015). "OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation". Brain: A Journal of Neurology. 138 (Pt 3): 563–576. doi:10.1093/brain/awu378. PMC 4339771. PMID 25564500.
Patten DA, Wong J, Khacho M, Soubannier V, Mailloux RJ, Pilon-Larose K, et al. (Nov 2014). "OPA1-dependent cristae modulation is essential for cellular adaptation to metabolic demand". The EMBO Journal. 33 (22): 2676–2691. doi:10.15252/embj.201488349. PMC 4282575. PMID 25298396.
Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, et al. (Mar 2014). "The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission". The Journal of Cell Biology. 204 (6): 919–929. doi:10.1083/jcb.201308006. PMC 3998800. PMID 24616225.
Wiemerslage L, Lee D (Mar 2016). "Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters". Journal of Neuroscience Methods. 262: 56–65. doi:10.1016/j.jneumeth.2016.01.008. PMC 4775301. PMID 26777473.
Carelli V, Musumeci O, Caporali L, Zanna C, La Morgia C, Del Dotto V, et al. (Mar 2015). "Syndromic parkinsonism and dementia associated with OPA1 missense mutations". Annals of Neurology. 78 (1): 21–38. doi:10.1002/ana.24410. PMC 5008165. PMID 25820230.
McKenty T, Ali S, Sonntag D, Ravipaty S, Cui Y, Slate D, et al. (2024-10-01). "Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells". Nucleic Acid Therapeutics. 34 (5): 221–233. doi:10.1089/nat.2024.0022. ISSN 2159-3337. PMC 11564677. PMID 39264859.
Fülöp L, Szanda G, Enyedi B, Várnai P, Spät A (2011). "The effect of OPA1 on mitochondrial Ca²⁺ signaling". PLOS ONE. 6 (9): e25199. doi:10.1371/journal.pone.0025199. PMC 3182975. PMID 21980395.
Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, et al. (Jun 2015). "The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage". Cell Metabolism. 21 (6): 834–844. doi:10.1016/j.cmet.2015.05.007. PMC 4457892. PMID 26039448.

pubmed.ncbi.nlm.nih.gov

Votruba M, Moore AT, Bhattacharya SS (Jan 1998). "Demonstration of a founder effect and fine mapping of dominant optic atrophy locus on 3q28-qter by linkage disequilibrium method: a study of 38 British Isles pedigrees". Human Genetics. 102 (1): 79–86. doi:10.1007/s004390050657. PMID 9490303. S2CID 26060748.
Santarelli R, Rossi R, Scimemi P, Cama E, Valentino ML, La Morgia C, et al. (Mar 2015). "OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation". Brain: A Journal of Neurology. 138 (Pt 3): 563–576. doi:10.1093/brain/awu378. PMC 4339771. PMID 25564500.
Patten DA, Wong J, Khacho M, Soubannier V, Mailloux RJ, Pilon-Larose K, et al. (Nov 2014). "OPA1-dependent cristae modulation is essential for cellular adaptation to metabolic demand". The EMBO Journal. 33 (22): 2676–2691. doi:10.15252/embj.201488349. PMC 4282575. PMID 25298396.
Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, et al. (Mar 2014). "The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission". The Journal of Cell Biology. 204 (6): 919–929. doi:10.1083/jcb.201308006. PMC 3998800. PMID 24616225.
Wiemerslage L, Lee D (Mar 2016). "Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters". Journal of Neuroscience Methods. 262: 56–65. doi:10.1016/j.jneumeth.2016.01.008. PMC 4775301. PMID 26777473.
Carelli V, Musumeci O, Caporali L, Zanna C, La Morgia C, Del Dotto V, et al. (Mar 2015). "Syndromic parkinsonism and dementia associated with OPA1 missense mutations". Annals of Neurology. 78 (1): 21–38. doi:10.1002/ana.24410. PMC 5008165. PMID 25820230.
Fülöp L, Rajki A, Katona D, Szanda G, Spät A (Dec 2013). "Extramitochondrial OPA1 and adrenocortical function" (PDF). Molecular and Cellular Endocrinology. 381 (1–2): 70–79. doi:10.1016/j.mce.2013.07.021. PMID 23906536. S2CID 5657510.
McKenty T, Ali S, Sonntag D, Ravipaty S, Cui Y, Slate D, et al. (2024-10-01). "Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells". Nucleic Acid Therapeutics. 34 (5): 221–233. doi:10.1089/nat.2024.0022. ISSN 2159-3337. PMC 11564677. PMID 39264859.
Fülöp L, Szanda G, Enyedi B, Várnai P, Spät A (2011). "The effect of OPA1 on mitochondrial Ca²⁺ signaling". PLOS ONE. 6 (9): e25199. doi:10.1371/journal.pone.0025199. PMC 3182975. PMID 21980395.
Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, et al. (Jun 2015). "The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage". Cell Metabolism. 21 (6): 834–844. doi:10.1016/j.cmet.2015.05.007. PMC 4457892. PMID 26039448.

semanticscholar.org

api.semanticscholar.org

Votruba M, Moore AT, Bhattacharya SS (Jan 1998). "Demonstration of a founder effect and fine mapping of dominant optic atrophy locus on 3q28-qter by linkage disequilibrium method: a study of 38 British Isles pedigrees". Human Genetics. 102 (1): 79–86. doi:10.1007/s004390050657. PMID 9490303. S2CID 26060748.
Fülöp L, Rajki A, Katona D, Szanda G, Spät A (Dec 2013). "Extramitochondrial OPA1 and adrenocortical function" (PDF). Molecular and Cellular Endocrinology. 381 (1–2): 70–79. doi:10.1016/j.mce.2013.07.021. PMID 23906536. S2CID 5657510.

worldcat.org

search.worldcat.org

McKenty T, Ali S, Sonntag D, Ravipaty S, Cui Y, Slate D, et al. (2024-10-01). "Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells". Nucleic Acid Therapeutics. 34 (5): 221–233. doi:10.1089/nat.2024.0022. ISSN 2159-3337. PMC 11564677. PMID 39264859.